Songwen Zhou

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Case Report: Complete pathologic response to neoadjuvant immunotherapy-chemotherapy in a patient with RET fusion-positive non-small cell lung cancer.

Case Report: Complete pathologic response to neoadjuvant immunotherapy-chemotherapy in a patient with RET fusion-positive non-small cell lung cancer.

Journal: Frontiers in oncology
Published: October 23, 2025

METTL14 enhances the m6A modification level of lncRNA MSTRG.292666.16 to promote the progression of non-small cell lung cancer.

METTL14 enhances the m6A modification level of lncRNA MSTRG.292666.16 to promote the progression of non-small cell lung cancer.

Journal: Cancer cell international
Published: August 29, 2023

Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer.

Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer.

Journal: Frontiers in oncology
Published: December 05, 2022

Exosomes derived from M2 type tumor-associated macrophages promote osimertinib resistance in non-small cell lung cancer through MSTRG.292666.16-miR-6836-5p-MAPK8IP3 axis.

Exosomes derived from M2 type tumor-associated macrophages promote osimertinib resistance in non-small cell lung cancer through MSTRG.292666.16-miR-6836-5p-MAPK8IP3 axis.

Journal: Cancer cell international
Published: August 23, 2021

Predictive value of unmethylated RASSF1A on disease progression in non-small cell lung cancer patients receiving pemetrexed-based chemotherapy.

Predictive value of unmethylated RASSF1A on disease progression in non-small cell lung cancer patients receiving pemetrexed-based chemotherapy.

Journal: Cancer biomarkers : section A of Disease markers
Published: December 17, 2019

Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without pathologic diagnosis.

Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without pathologic diagnosis.

Journal: Cancer medicine
Published: September 27, 2019

A novel virtual barcode strategy for accurate panel-wide variant calling in circulating tumor DNA.

A novel virtual barcode strategy for accurate panel-wide variant calling in circulating tumor DNA.

Journal: BMC bioinformatics
Published: September 18, 2019

Exosomal long non-coding RNA MSTRG.292666.16 is associated with osimertinib (AZD9291) resistance in non-small cell lung cancer.

Exosomal long non-coding RNA MSTRG.292666.16 is associated with osimertinib (AZD9291) resistance in non-small cell lung cancer.

Journal: Aging
Published: June 27, 2019

Competitive evolution of NSCLC tumor clones and the drug resistance mechanism of first-generation EGFR-TKIs in Chinese NSCLC patients.

Competitive evolution of NSCLC tumor clones and the drug resistance mechanism of first-generation EGFR-TKIs in Chinese NSCLC patients.

Journal: Heliyon
Published: June 03, 2018

Engineering docetaxel-loaded micelles for non-small cell lung cancer: a comparative study of microfluidic and bulk nanoparticle preparation.

Engineering docetaxel-loaded micelles for non-small cell lung cancer: a comparative study of microfluidic and bulk nanoparticle preparation.

Journal: RSC advances
Published: May 27, 2018

Relationship between ID1 and EGFR-TKI Resistance 
in Non-small Cell Lung Cancer

Relationship between ID1 and EGFR-TKI Resistance 
in Non-small Cell Lung Cancer

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: December 17, 2016

The Evolution and Expression Pattern of Human Overlapping lncRNA and Protein-coding Gene Pairs.

The Evolution and Expression Pattern of Human Overlapping lncRNA and Protein-coding Gene Pairs.

Journal: Scientific reports
Published: November 16, 2016
Showing 1-12 of 20

Last Updated: 09/26/2026